Korro Bio, KRRO-121, ANCHOR, RNA Editing, OPERA, Oligonucleotide, Genetic Medicine, Urea Cycle Disorders, UCD, Hyperammonemia, Hepatic Encephalopathy,

CAMBRIDGE, Mass. — October 5, 2026 Korro Bio, Inc. announced that the first cohort of participants has been dosed...